Serveur d'exploration sur la recherche en informatique en Lorraine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Induced fit in liver X receptor beta: A molecular dynamics‐based investigation

Identifieur interne : 001E26 ( Istex/Corpus ); précédent : 001E25; suivant : 001E27

Induced fit in liver X receptor beta: A molecular dynamics‐based investigation

Auteurs : Alexandre Beautrait ; Arnaud S. Karaboga ; Michel Souchet ; Bernard Maigret

Source :

RBID : ISTEX:826C476329C9B8BD122A2ACB403ADC4936D98858

English descriptors

Abstract

Ligand induced fit phenomenon occurring at the ligand binding domain of the liver X receptor beta (LXRβ) was investigated by means of molecular dynamics. Reliability of a 4‐ns trajectory was tested from two distinct LXRβ crystal complexes 1PQ6B/GW and 1PQ9B/T09 characterized by an open and a closed state of the pocket, respectively. Crossed complexes 1PQ6B/T09 and 1PQ9B/GW were then submitted to the same molecular dynamic conditions, which were able to recover LXRβ conformations similar to the original crystallography data. Analysis of “open to closed” and “closed to open” conformational transitions pointed out the dynamic role of critical residues lining the ligand binding pocket involved in the local remodeling upon ligand binding (e.g., Phe271, Phe329, Phe340, Arg319, Glu281). Altogether, the present study indicates that the molecular dynamic protocol is a consistent approach for managing LXRβ‐related induced fit process. This protocol could therefore be used for refining ligand docking solutions of a structure‐based design strategy. Proteins 2008. © 2008 Wiley‐Liss, Inc.

Url:
DOI: 10.1002/prot.21977

Links to Exploration step

ISTEX:826C476329C9B8BD122A2ACB403ADC4936D98858

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Induced fit in liver X receptor beta: A molecular dynamics‐based investigation</title>
<author>
<name sortKey="Beautrait, Alexandre" sort="Beautrait, Alexandre" uniqKey="Beautrait A" first="Alexandre" last="Beautrait">Alexandre Beautrait</name>
<affiliation>
<mods:affiliation>Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Karaboga, Arnaud S" sort="Karaboga, Arnaud S" uniqKey="Karaboga A" first="Arnaud S." last="Karaboga">Arnaud S. Karaboga</name>
<affiliation>
<mods:affiliation>Laboratoires Fournier, a Solvay Pharmaceuticals company, 50 rue de Dijon, 21121 Daix, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Souchet, Michel" sort="Souchet, Michel" uniqKey="Souchet M" first="Michel" last="Souchet">Michel Souchet</name>
<affiliation>
<mods:affiliation>Laboratoires Fournier, a Solvay Pharmaceuticals company, 50 rue de Dijon, 21121 Daix, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: michel.souchet@solvay.com</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Michel Souchet, Laboratoires Fournier, a Solvay Pharmaceuticals Company, 50 rue de Dijon, 21121 Daix, France===Bernard Maigret, Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France===</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Maigret, Bernard" sort="Maigret, Bernard" uniqKey="Maigret B" first="Bernard" last="Maigret">Bernard Maigret</name>
<affiliation>
<mods:affiliation>Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: bernard.maigret@loria.fr</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Michel Souchet, Laboratoires Fournier, a Solvay Pharmaceuticals Company, 50 rue de Dijon, 21121 Daix, France===Bernard Maigret, Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France===</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:826C476329C9B8BD122A2ACB403ADC4936D98858</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/prot.21977</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-1GHF12RV-X/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001E26</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001E26</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Induced fit in liver X receptor beta: A molecular dynamics‐based investigation</title>
<author>
<name sortKey="Beautrait, Alexandre" sort="Beautrait, Alexandre" uniqKey="Beautrait A" first="Alexandre" last="Beautrait">Alexandre Beautrait</name>
<affiliation>
<mods:affiliation>Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Karaboga, Arnaud S" sort="Karaboga, Arnaud S" uniqKey="Karaboga A" first="Arnaud S." last="Karaboga">Arnaud S. Karaboga</name>
<affiliation>
<mods:affiliation>Laboratoires Fournier, a Solvay Pharmaceuticals company, 50 rue de Dijon, 21121 Daix, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Souchet, Michel" sort="Souchet, Michel" uniqKey="Souchet M" first="Michel" last="Souchet">Michel Souchet</name>
<affiliation>
<mods:affiliation>Laboratoires Fournier, a Solvay Pharmaceuticals company, 50 rue de Dijon, 21121 Daix, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: michel.souchet@solvay.com</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Michel Souchet, Laboratoires Fournier, a Solvay Pharmaceuticals Company, 50 rue de Dijon, 21121 Daix, France===Bernard Maigret, Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France===</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Maigret, Bernard" sort="Maigret, Bernard" uniqKey="Maigret B" first="Bernard" last="Maigret">Bernard Maigret</name>
<affiliation>
<mods:affiliation>Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: bernard.maigret@loria.fr</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Michel Souchet, Laboratoires Fournier, a Solvay Pharmaceuticals Company, 50 rue de Dijon, 21121 Daix, France===Bernard Maigret, Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France===</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Proteins: Structure, Function, and Bioinformatics</title>
<title level="j" type="alt">PROTEINS: STRUCTURE, FUNCTION, AND BIOINFORMATICS</title>
<idno type="ISSN">0887-3585</idno>
<idno type="eISSN">1097-0134</idno>
<imprint>
<biblScope unit="vol">72</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="873">873</biblScope>
<biblScope unit="page" to="882">882</biblScope>
<biblScope unit="page-count">10</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-08-15">2008-08-15</date>
</imprint>
<idno type="ISSN">0887-3585</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0887-3585</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acidic group</term>
<term>Acidic moiety</term>
<term>Activation function</term>
<term>Activation helix</term>
<term>Active conformation</term>
<term>Agonist</term>
<term>Average distance</term>
<term>Average rmsd</term>
<term>Average rmsd value</term>
<term>Binding domain</term>
<term>Binding pocket</term>
<term>Biol</term>
<term>Biol chem</term>
<term>Bisphenyl group</term>
<term>Bisphenyl moiety</term>
<term>Campus scientifique</term>
<term>Carboxylate moiety</term>
<term>Chem</term>
<term>Color figure</term>
<term>Complexed</term>
<term>Comput chem</term>
<term>Conformation</term>
<term>Crucial role</term>
<term>Crystal structure</term>
<term>Crystal structures</term>
<term>Different shapes</term>
<term>Drug design</term>
<term>Dynamics</term>
<term>Electrostatic interaction</term>
<term>Equilibration phase</term>
<term>Extreme shapes</term>
<term>Groupe orpailleur</term>
<term>Helix</term>
<term>Hydrophobic</term>
<term>Interaction energy</term>
<term>Laboratoires fournier</term>
<term>Ligand</term>
<term>Ligand binding</term>
<term>Ligand binding domain</term>
<term>Ligand binding pocket</term>
<term>Lxrb</term>
<term>Lxrb complexed</term>
<term>Lxrb lbds complexed</term>
<term>Moiety</term>
<term>Molecular dynamics</term>
<term>Molecular dynamics simulations</term>
<term>Molecular dynamics study</term>
<term>Nuclear receptor</term>
<term>Nuclear receptors</term>
<term>Online</term>
<term>Online issue</term>
<term>Phenylsulfonyl group</term>
<term>Phenylsulfonyl moiety</term>
<term>Phys chem</term>
<term>Polar residues</term>
<term>Present study</term>
<term>Protonation</term>
<term>Protonation state</term>
<term>Receptor</term>
<term>Receptor beta</term>
<term>Reference system</term>
<term>Reference systems</term>
<term>Residue</term>
<term>Respective ligand</term>
<term>Salt bridge</term>
<term>Sbdd strategy</term>
<term>Side chain</term>
<term>Simulation</term>
<term>Solvay pharmaceuticals company</term>
<term>Structural analysis</term>
<term>Synthetic ligands</term>
<term>Trajectory</term>
<term>Water molecule</term>
<term>Water molecules</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Ligand induced fit phenomenon occurring at the ligand binding domain of the liver X receptor beta (LXRβ) was investigated by means of molecular dynamics. Reliability of a 4‐ns trajectory was tested from two distinct LXRβ crystal complexes 1PQ6B/GW and 1PQ9B/T09 characterized by an open and a closed state of the pocket, respectively. Crossed complexes 1PQ6B/T09 and 1PQ9B/GW were then submitted to the same molecular dynamic conditions, which were able to recover LXRβ conformations similar to the original crystallography data. Analysis of “open to closed” and “closed to open” conformational transitions pointed out the dynamic role of critical residues lining the ligand binding pocket involved in the local remodeling upon ligand binding (e.g., Phe271, Phe329, Phe340, Arg319, Glu281). Altogether, the present study indicates that the molecular dynamic protocol is a consistent approach for managing LXRβ‐related induced fit process. This protocol could therefore be used for refining ligand docking solutions of a structure‐based design strategy. Proteins 2008. © 2008 Wiley‐Liss, Inc.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<keywords>
<teeft>
<json:string>receptor</json:string>
<json:string>ligand</json:string>
<json:string>lxrb</json:string>
<json:string>agonist</json:string>
<json:string>chem</json:string>
<json:string>moiety</json:string>
<json:string>biol</json:string>
<json:string>reference systems</json:string>
<json:string>helix</json:string>
<json:string>complexed</json:string>
<json:string>online</json:string>
<json:string>water molecules</json:string>
<json:string>protonation</json:string>
<json:string>online issue</json:string>
<json:string>color figure</json:string>
<json:string>salt bridge</json:string>
<json:string>water molecule</json:string>
<json:string>protonation state</json:string>
<json:string>crystal structure</json:string>
<json:string>simulation</json:string>
<json:string>equilibration phase</json:string>
<json:string>drug design</json:string>
<json:string>molecular dynamics</json:string>
<json:string>crystal structures</json:string>
<json:string>ligand binding pocket</json:string>
<json:string>structural analysis</json:string>
<json:string>activation function</json:string>
<json:string>trajectory</json:string>
<json:string>hydrophobic</json:string>
<json:string>conformation</json:string>
<json:string>receptor beta</json:string>
<json:string>nuclear receptors</json:string>
<json:string>lxrb complexed</json:string>
<json:string>ligand binding domain</json:string>
<json:string>comput chem</json:string>
<json:string>side chain</json:string>
<json:string>crucial role</json:string>
<json:string>active conformation</json:string>
<json:string>average rmsd</json:string>
<json:string>molecular dynamics simulations</json:string>
<json:string>average distance</json:string>
<json:string>nuclear receptor</json:string>
<json:string>biol chem</json:string>
<json:string>dynamics</json:string>
<json:string>phenylsulfonyl group</json:string>
<json:string>binding domain</json:string>
<json:string>synthetic ligands</json:string>
<json:string>sbdd strategy</json:string>
<json:string>carboxylate moiety</json:string>
<json:string>bisphenyl group</json:string>
<json:string>phenylsulfonyl moiety</json:string>
<json:string>ligand binding</json:string>
<json:string>extreme shapes</json:string>
<json:string>average rmsd value</json:string>
<json:string>present study</json:string>
<json:string>solvay pharmaceuticals company</json:string>
<json:string>acidic group</json:string>
<json:string>reference system</json:string>
<json:string>interaction energy</json:string>
<json:string>lxrb lbds complexed</json:string>
<json:string>laboratoires fournier</json:string>
<json:string>bisphenyl moiety</json:string>
<json:string>different shapes</json:string>
<json:string>acidic moiety</json:string>
<json:string>respective ligand</json:string>
<json:string>campus scientifique</json:string>
<json:string>binding pocket</json:string>
<json:string>groupe orpailleur</json:string>
<json:string>activation helix</json:string>
<json:string>electrostatic interaction</json:string>
<json:string>polar residues</json:string>
<json:string>phys chem</json:string>
<json:string>molecular dynamics study</json:string>
<json:string>residue</json:string>
</teeft>
</keywords>
<author>
<json:item>
<name>Alexandre Beautrait</name>
<affiliations>
<json:string>Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Arnaud S. Karaboga</name>
<affiliations>
<json:string>Laboratoires Fournier, a Solvay Pharmaceuticals company, 50 rue de Dijon, 21121 Daix, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Michel Souchet</name>
<affiliations>
<json:string>Laboratoires Fournier, a Solvay Pharmaceuticals company, 50 rue de Dijon, 21121 Daix, France</json:string>
<json:string>E-mail: michel.souchet@solvay.com</json:string>
<json:string>Michel Souchet, Laboratoires Fournier, a Solvay Pharmaceuticals Company, 50 rue de Dijon, 21121 Daix, France===Bernard Maigret, Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France===</json:string>
</affiliations>
</json:item>
<json:item>
<name>Bernard Maigret</name>
<affiliations>
<json:string>Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France</json:string>
<json:string>E-mail: bernard.maigret@loria.fr</json:string>
<json:string>Michel Souchet, Laboratoires Fournier, a Solvay Pharmaceuticals Company, 50 rue de Dijon, 21121 Daix, France===Bernard Maigret, Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France===</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>induced fit</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>liver X receptor</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>molecular dynamics</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>protein flexibility</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>structure‐based drug design</value>
</json:item>
</subject>
<articleId>
<json:string>PROT21977</json:string>
</articleId>
<arkIstex>ark:/67375/WNG-1GHF12RV-X</arkIstex>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>article</json:string>
</originalGenre>
<abstract>Ligand induced fit phenomenon occurring at the ligand binding domain of the liver X receptor beta (LXRβ) was investigated by means of molecular dynamics. Reliability of a 4‐ns trajectory was tested from two distinct LXRβ crystal complexes 1PQ6B/GW and 1PQ9B/T09 characterized by an open and a closed state of the pocket, respectively. Crossed complexes 1PQ6B/T09 and 1PQ9B/GW were then submitted to the same molecular dynamic conditions, which were able to recover LXRβ conformations similar to the original crystallography data. Analysis of “open to closed” and “closed to open” conformational transitions pointed out the dynamic role of critical residues lining the ligand binding pocket involved in the local remodeling upon ligand binding (e.g., Phe271, Phe329, Phe340, Arg319, Glu281). Altogether, the present study indicates that the molecular dynamic protocol is a consistent approach for managing LXRβ‐related induced fit process. This protocol could therefore be used for refining ligand docking solutions of a structure‐based design strategy. Proteins 2008. © 2008 Wiley‐Liss, Inc.</abstract>
<qualityIndicators>
<score>8.908</score>
<pdfWordCount>5787</pdfWordCount>
<pdfCharCount>35480</pdfCharCount>
<pdfVersion>1.3</pdfVersion>
<pdfPageCount>10</pdfPageCount>
<pdfPageSize>612 x 810 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractWordCount>159</abstractWordCount>
<abstractCharCount>1091</abstractCharCount>
<keywordCount>5</keywordCount>
</qualityIndicators>
<title>Induced fit in liver X receptor beta: A molecular dynamics‐based investigation</title>
<pmid>
<json:string>18275080</json:string>
</pmid>
<genre>
<json:string>article</json:string>
</genre>
<host>
<title>Proteins: Structure, Function, and Bioinformatics</title>
<language>
<json:string>unknown</json:string>
</language>
<doi>
<json:string>10.1002/(ISSN)1097-0134</json:string>
</doi>
<issn>
<json:string>0887-3585</json:string>
</issn>
<eissn>
<json:string>1097-0134</json:string>
</eissn>
<publisherId>
<json:string>PROT</json:string>
</publisherId>
<volume>72</volume>
<issue>3</issue>
<pages>
<first>873</first>
<last>882</last>
<total>10</total>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
<subject>
<json:item>
<value>Research Article</value>
</json:item>
</subject>
</host>
<namedEntities>
<unitex>
<date></date>
<geogName></geogName>
<orgName></orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName></persName>
<placeName></placeName>
<ref_url></ref_url>
<ref_bibl></ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark>
<json:string>ark:/67375/WNG-1GHF12RV-X</json:string>
</ark>
<categories>
<wos>
<json:string>1 - science</json:string>
<json:string>2 - biophysics</json:string>
<json:string>2 - biochemistry & molecular biology</json:string>
</wos>
<scienceMetrix>
<json:string>1 - applied sciences</json:string>
<json:string>2 - enabling & strategic technologies</json:string>
<json:string>3 - bioinformatics</json:string>
</scienceMetrix>
<scopus>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Molecular Biology</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Biochemistry</json:string>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Structural Biology</json:string>
</scopus>
<inist>
<json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences biologiques fondamentales et appliquees. psychologie</json:string>
<json:string>4 - vertebres: systeme digestif</json:string>
</inist>
</categories>
<publicationDate>2008</publicationDate>
<copyrightDate>2008</copyrightDate>
<doi>
<json:string>10.1002/prot.21977</json:string>
</doi>
<id>826C476329C9B8BD122A2ACB403ADC4936D98858</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-1GHF12RV-X/fulltext.pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-1GHF12RV-X/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-1GHF12RV-X/fulltext.tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Induced fit in liver X receptor beta: A molecular dynamics‐based investigation</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability>
<licence>Copyright © 2008 Wiley‐Liss, Inc.</licence>
</availability>
<date type="published" when="2008-08-15"></date>
</publicationStmt>
<notesStmt>
<note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note>
<note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc>
<biblStruct type="article">
<analytic>
<title level="a" type="main" xml:lang="en">Induced fit in liver X receptor beta: A molecular dynamics‐based investigation</title>
<title level="a" type="short" xml:lang="en">Investigation of the LXRβ‐Induced Fit by MD</title>
<author xml:id="author-0000">
<persName>
<forename type="first">Alexandre</forename>
<surname>Beautrait</surname>
</persName>
<affiliation>
<orgName type="institution">Nancy‐Université</orgName>
<address>
<addrLine>groupe ORPAILLEUR</addrLine>
<addrLine>UMR CNRS/UHP 7503</addrLine>
<addrLine>LORIA</addrLine>
<addrLine>Campus scientifique</addrLine>
<addrLine>BP239</addrLine>
<addrLine>54506 Vandœuvre‐lès‐Nancy Cedex</addrLine>
<country key="FR">FRANCE</country>
<country key="FR"></country>
</address>
</affiliation>
<note type="foot">Alexandre Beautrait and Arnaud S. Karaboga contributed equally to this work.</note>
</author>
<author xml:id="author-0001">
<persName>
<forename type="first">Arnaud S.</forename>
<surname>Karaboga</surname>
</persName>
<affiliation>
<orgName type="laboratory">Laboratoires Fournier</orgName>
<address>
<addrLine>a Solvay Pharmaceuticals company</addrLine>
<addrLine>50 rue de Dijon</addrLine>
<addrLine>21121 Daix</addrLine>
<country key="FR">FRANCE</country>
<country key="FR"></country>
</address>
</affiliation>
<note type="foot">Alexandre Beautrait and Arnaud S. Karaboga contributed equally to this work.</note>
</author>
<author xml:id="author-0002" role="corresp">
<persName>
<forename type="first">Michel</forename>
<surname>Souchet</surname>
</persName>
<email>michel.souchet@solvay.com</email>
<affiliation>
<orgName type="laboratory">Laboratoires Fournier</orgName>
<address>
<addrLine>a Solvay Pharmaceuticals company</addrLine>
<addrLine>50 rue de Dijon</addrLine>
<addrLine>21121 Daix</addrLine>
<country key="FR">FRANCE</country>
<country key="FR"></country>
</address>
</affiliation>
<affiliation>Michel Souchet, Laboratoires Fournier, a Solvay Pharmaceuticals Company, 50 rue de Dijon, 21121 Daix, France=== Bernard Maigret, Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France===</affiliation>
</author>
<author xml:id="author-0003" role="corresp">
<persName>
<forename type="first">Bernard</forename>
<surname>Maigret</surname>
</persName>
<email>bernard.maigret@loria.fr</email>
<affiliation>
<orgName type="institution">Nancy‐Université</orgName>
<address>
<addrLine>groupe ORPAILLEUR</addrLine>
<addrLine>UMR CNRS/UHP 7503</addrLine>
<addrLine>LORIA</addrLine>
<addrLine>Campus scientifique</addrLine>
<addrLine>BP239</addrLine>
<addrLine>54506 Vandœuvre‐lès‐Nancy Cedex</addrLine>
<country key="FR">FRANCE</country>
<country key="FR"></country>
</address>
</affiliation>
<affiliation>Michel Souchet, Laboratoires Fournier, a Solvay Pharmaceuticals Company, 50 rue de Dijon, 21121 Daix, France=== Bernard Maigret, Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France===</affiliation>
</author>
<idno type="istex">826C476329C9B8BD122A2ACB403ADC4936D98858</idno>
<idno type="ark">ark:/67375/WNG-1GHF12RV-X</idno>
<idno type="DOI">10.1002/prot.21977</idno>
<idno type="unit">PROT21977</idno>
<idno type="toTypesetVersion">file:PROT.PROT21977.pdf</idno>
</analytic>
<monogr>
<title level="j" type="main">Proteins: Structure, Function, and Bioinformatics</title>
<title level="j" type="alt">PROTEINS: STRUCTURE, FUNCTION, AND BIOINFORMATICS</title>
<idno type="pISSN">0887-3585</idno>
<idno type="eISSN">1097-0134</idno>
<idno type="book-DOI">10.1002/(ISSN)1097-0134</idno>
<idno type="book-part-DOI">10.1002/prot.v72:3</idno>
<idno type="product">PROT</idno>
<imprint>
<biblScope unit="vol">72</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="873">873</biblScope>
<biblScope unit="page" to="882">882</biblScope>
<biblScope unit="page-count">10</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-08-15"></date>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<abstract xml:lang="en" style="main">
<head>Abstract</head>
<p>Ligand induced fit phenomenon occurring at the ligand binding domain of the liver X receptor beta (LXRβ) was investigated by means of molecular dynamics. Reliability of a 4‐ns trajectory was tested from two distinct LXRβ crystal complexes 1PQ6B/GW and 1PQ9B/T09 characterized by an open and a closed state of the pocket, respectively. Crossed complexes 1PQ6B/T09 and 1PQ9B/GW were then submitted to the same molecular dynamic conditions, which were able to recover LXRβ conformations similar to the original crystallography data. Analysis of “open to closed” and “closed to open” conformational transitions pointed out the dynamic role of critical residues lining the ligand binding pocket involved in the local remodeling upon ligand binding (e.g., Phe271, Phe329, Phe340, Arg319, Glu281). Altogether, the present study indicates that the molecular dynamic protocol is a consistent approach for managing LXRβ‐related induced fit process. This protocol could therefore be used for refining ligand docking solutions of a structure‐based design strategy. Proteins 2008. © 2008 Wiley‐Liss, Inc.</p>
</abstract>
<textClass>
<keywords xml:lang="en">
<term xml:id="kwd1">induced fit</term>
<term xml:id="kwd2">liver X receptor</term>
<term xml:id="kwd3">molecular dynamics</term>
<term xml:id="kwd4">protein flexibility</term>
<term xml:id="kwd5">structure‐based drug design</term>
</keywords>
<keywords rend="articleCategory">
<term>Research Article</term>
</keywords>
<keywords rend="tocHeading1">
<term>Research Articles</term>
</keywords>
</textClass>
<langUsage>
<language ident="en"></language>
</langUsage>
</profileDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-1GHF12RV-X/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1097-0134</doi>
<issn type="print">0887-3585</issn>
<issn type="electronic">1097-0134</issn>
<idGroup>
<id type="product" value="PROT"></id>
</idGroup>
<titleGroup>
<title type="main" xml:lang="en" sort="PROTEINS: STRUCTURE, FUNCTION, AND BIOINFORMATICS">Proteins: Structure, Function, and Bioinformatics</title>
<title type="short">Proteins</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="30">
<doi origin="wiley" registered="yes">10.1002/prot.v72:3</doi>
<numberingGroup>
<numbering type="journalVolume" number="72">72</numbering>
<numbering type="journalIssue">3</numbering>
</numberingGroup>
<coverDate startDate="2008-08-15">15 August 2008</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="60" status="forIssue">
<doi origin="wiley" registered="yes">10.1002/prot.21977</doi>
<idGroup>
<id type="unit" value="PROT21977"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="10"></count>
</countGroup>
<titleGroup>
<title type="articleCategory">Research Article</title>
<title type="tocHeading1">Research Articles</title>
</titleGroup>
<copyright ownership="publisher">Copyright © 2008 Wiley‐Liss, Inc.</copyright>
<eventGroup>
<event type="manuscriptReceived" date="2007-10-26"></event>
<event type="manuscriptRevised" date="2007-12-18"></event>
<event type="manuscriptAccepted" date="2007-12-20"></event>
<event type="publishedOnlineEarlyUnpaginated" date="2008-02-14"></event>
<event type="firstOnline" date="2008-02-14"></event>
<event type="publishedOnlineFinalForm" date="2008-07-08"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.16 mode:FullText" date="2010-08-19"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-20"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-03"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst">873</numbering>
<numbering type="pageLast">882</numbering>
</numberingGroup>
<correspondenceTo>
<lineatedText>
<line>Michel Souchet, Laboratoires Fournier, a Solvay Pharmaceuticals Company, 50 rue de Dijon, 21121 Daix, France===</line>
<line>Bernard Maigret, Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France===</line>
</lineatedText>
</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:PROT.PROT21977.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="9"></count>
<count type="tableTotal" number="0"></count>
<count type="referenceTotal" number="42"></count>
<count type="wordTotal" number="6047"></count>
</countGroup>
<titleGroup>
<title type="main" xml:lang="en">Induced fit in liver X receptor beta: A molecular dynamics‐based investigation</title>
<title type="short" xml:lang="en">Investigation of the LXRβ‐Induced Fit by MD</title>
</titleGroup>
<creators>
<creator xml:id="au1" creatorRole="author" affiliationRef="#af1" noteRef="#fn1">
<personName>
<givenNames>Alexandre</givenNames>
<familyName>Beautrait</familyName>
</personName>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af2" noteRef="#fn1">
<personName>
<givenNames>Arnaud S.</givenNames>
<familyName>Karaboga</familyName>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af2" corresponding="yes">
<personName>
<givenNames>Michel</givenNames>
<familyName>Souchet</familyName>
</personName>
<contactDetails>
<email>michel.souchet@solvay.com</email>
</contactDetails>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af1" corresponding="yes">
<personName>
<givenNames>Bernard</givenNames>
<familyName>Maigret</familyName>
</personName>
<contactDetails>
<email>bernard.maigret@loria.fr</email>
</contactDetails>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="af1" countryCode="FR" type="organization">
<unparsedAffiliation>Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="FR" type="organization">
<unparsedAffiliation>Laboratoires Fournier, a Solvay Pharmaceuticals company, 50 rue de Dijon, 21121 Daix, France</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author">
<keyword xml:id="kwd1">induced fit</keyword>
<keyword xml:id="kwd2">liver X receptor</keyword>
<keyword xml:id="kwd3">molecular dynamics</keyword>
<keyword xml:id="kwd4">protein flexibility</keyword>
<keyword xml:id="kwd5">structure‐based drug design</keyword>
</keywordGroup>
<fundingInfo>
<fundingAgency>Association pour la Recherche sur le Cancer (ARC)</fundingAgency>
<fundingNumber>JR/MLD/MDV‐A06/4</fundingNumber>
</fundingInfo>
<abstractGroup>
<abstract type="main" xml:lang="en">
<title type="main">Abstract</title>
<p>Ligand induced fit phenomenon occurring at the ligand binding domain of the liver X receptor beta (LXRβ) was investigated by means of molecular dynamics. Reliability of a 4‐ns trajectory was tested from two distinct LXRβ crystal complexes 1PQ6B/GW and 1PQ9B/T09 characterized by an open and a closed state of the pocket, respectively. Crossed complexes 1PQ6B/T09 and 1PQ9B/GW were then submitted to the same molecular dynamic conditions, which were able to recover LXRβ conformations similar to the original crystallography data. Analysis of “open to closed” and “closed to open” conformational transitions pointed out the dynamic role of critical residues lining the ligand binding pocket involved in the local remodeling upon ligand binding (e.g., Phe271, Phe329, Phe340, Arg319, Glu281). Altogether, the present study indicates that the molecular dynamic protocol is a consistent approach for managing LXRβ‐related induced fit process. This protocol could therefore be used for refining ligand docking solutions of a structure‐based design strategy. Proteins 2008. © 2008 Wiley‐Liss, Inc.</p>
</abstract>
</abstractGroup>
</contentMeta>
<noteGroup>
<note xml:id="fn1">
<p>Alexandre Beautrait and Arnaud S. Karaboga contributed equally to this work.</p>
</note>
</noteGroup>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Induced fit in liver X receptor beta: A molecular dynamics‐based investigation</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>Investigation of the LXRβ‐Induced Fit by MD</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Induced fit in liver X receptor beta: A molecular dynamics‐based investigation</title>
</titleInfo>
<name type="personal">
<namePart type="given">Alexandre</namePart>
<namePart type="family">Beautrait</namePart>
<affiliation>Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France</affiliation>
<description>Alexandre Beautrait and Arnaud S. Karaboga contributed equally to this work.</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Arnaud S.</namePart>
<namePart type="family">Karaboga</namePart>
<affiliation>Laboratoires Fournier, a Solvay Pharmaceuticals company, 50 rue de Dijon, 21121 Daix, France</affiliation>
<description>Alexandre Beautrait and Arnaud S. Karaboga contributed equally to this work.</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Michel</namePart>
<namePart type="family">Souchet</namePart>
<affiliation>Laboratoires Fournier, a Solvay Pharmaceuticals company, 50 rue de Dijon, 21121 Daix, France</affiliation>
<affiliation>E-mail: michel.souchet@solvay.com</affiliation>
<affiliation>Michel Souchet, Laboratoires Fournier, a Solvay Pharmaceuticals Company, 50 rue de Dijon, 21121 Daix, France===Bernard Maigret, Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France===</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Bernard</namePart>
<namePart type="family">Maigret</namePart>
<affiliation>Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France</affiliation>
<affiliation>E-mail: bernard.maigret@loria.fr</affiliation>
<affiliation>Michel Souchet, Laboratoires Fournier, a Solvay Pharmaceuticals Company, 50 rue de Dijon, 21121 Daix, France===Bernard Maigret, Nancy‐Université, groupe ORPAILLEUR, UMR CNRS/UHP 7503, LORIA, Campus scientifique, BP239, 54506 Vandœuvre‐lès‐Nancy Cedex, France===</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre>
<originInfo>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place>
<placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2008-08-15</dateIssued>
<dateCaptured encoding="w3cdtf">2007-10-26</dateCaptured>
<dateValid encoding="w3cdtf">2007-12-20</dateValid>
<copyrightDate encoding="w3cdtf">2008</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<extent unit="figures">9</extent>
<extent unit="tables">0</extent>
<extent unit="references">42</extent>
<extent unit="words">6047</extent>
</physicalDescription>
<abstract lang="en">Ligand induced fit phenomenon occurring at the ligand binding domain of the liver X receptor beta (LXRβ) was investigated by means of molecular dynamics. Reliability of a 4‐ns trajectory was tested from two distinct LXRβ crystal complexes 1PQ6B/GW and 1PQ9B/T09 characterized by an open and a closed state of the pocket, respectively. Crossed complexes 1PQ6B/T09 and 1PQ9B/GW were then submitted to the same molecular dynamic conditions, which were able to recover LXRβ conformations similar to the original crystallography data. Analysis of “open to closed” and “closed to open” conformational transitions pointed out the dynamic role of critical residues lining the ligand binding pocket involved in the local remodeling upon ligand binding (e.g., Phe271, Phe329, Phe340, Arg319, Glu281). Altogether, the present study indicates that the molecular dynamic protocol is a consistent approach for managing LXRβ‐related induced fit process. This protocol could therefore be used for refining ligand docking solutions of a structure‐based design strategy. Proteins 2008. © 2008 Wiley‐Liss, Inc.</abstract>
<note type="funding">Association pour la Recherche sur le Cancer (ARC) - No. JR/MLD/MDV‐A06/4; </note>
<subject lang="en">
<genre>keywords</genre>
<topic>induced fit</topic>
<topic>liver X receptor</topic>
<topic>molecular dynamics</topic>
<topic>protein flexibility</topic>
<topic>structure‐based drug design</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Proteins: Structure, Function, and Bioinformatics</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>Proteins</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<subject>
<genre>article-category</genre>
<topic>Research Article</topic>
</subject>
<identifier type="ISSN">0887-3585</identifier>
<identifier type="eISSN">1097-0134</identifier>
<identifier type="DOI">10.1002/(ISSN)1097-0134</identifier>
<identifier type="PublisherID">PROT</identifier>
<part>
<date>2008</date>
<detail type="volume">
<caption>vol.</caption>
<number>72</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>3</number>
</detail>
<extent unit="pages">
<start>873</start>
<end>882</end>
<total>10</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">826C476329C9B8BD122A2ACB403ADC4936D98858</identifier>
<identifier type="ark">ark:/67375/WNG-1GHF12RV-X</identifier>
<identifier type="DOI">10.1002/prot.21977</identifier>
<identifier type="ArticleID">PROT21977</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2008 Wiley‐Liss, Inc.</accessCondition>
<recordInfo>
<recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource>
<recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
</recordInfo>
</mods>
<json:item>
<extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-1GHF12RV-X/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Lorraine/explor/InforLorV4/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E26 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001E26 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Lorraine
   |area=    InforLorV4
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:826C476329C9B8BD122A2ACB403ADC4936D98858
   |texte=   Induced fit in liver X receptor beta: A molecular dynamics‐based investigation
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Jun 10 21:56:28 2019. Site generation: Fri Feb 25 15:29:27 2022